Companies: 10,795·Total market cap: $144.5T
Emergent BioSolutions Inc.

Emergent BioSolutions Inc.

EBSNYSEHealthcare● Active
$8.07
$-0.37(-4.38%)
Market Cap$416382141
P/E Ratio—
52W High$14.06
52W Low$5.62
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Emergent BioSolutions Inc. (EBS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · EBS · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.17ebs eps ttm · ebs earnings per shareEarnings history
PE Ratio (TTM)—ebs pe ratio ttm · ebs price to earningsPE Ratio deep dive
Revenue (TTM)$676.8Mebs revenue ttm · ebs annual revenueFull revenue history
Dividend YieldNo Dividenddoes ebs pay dividends · ebs dividend yieldDividend history
Shares Outstanding53.5Mebs shares outstanding · ebs floatShares outstanding history
Next EarningsAug 5, 2026Est.ebs earnings date · ebs next earningsEarnings history

Explore Emergent BioSolutions Inc. Data

ebs stock data · financials
Market Cap$416.4Mebs market cap · ebs valuation
Analyst Forecast$12 · Buy
DividendsNo Dividenddoes emergent biosolutions inc. pay dividends · ebs dividend yield
Revenue$742.9M-28.81%emergent biosolutions inc. annual revenue · ebs revenue
EarningsEPS $0.98+127.22%ebs earnings · ebs eps
PE Ratio—ebs pe ratio · ebs price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$742.9M▼ 28.81% YoY
202320242025
emergent biosolutions inc. revenue · ebs revenue 2025
FY 2025Net Income$52.6M▲ +127.60% YoY
202320242025
emergent biosolutions inc. net income · ebs profit 2025
FY 2025EPS$0.98▲ +127.22% YoY
202320242025
ebs eps · emergent biosolutions inc. earnings per share 2025
TTM:Revenue: $676.8MNet Income: -$8.6MEPS: $-0.17View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy15 analystsis ebs a buy · ebs analyst rating
Strong Buy
0
Buy
11
Hold
3
Sell
1
Strong Sell
0
12-Month Price Target
$12.00Low
$8.07Current
$12.00Avg Target48.70% upside
$12.00High
ebs price target · ebs 12 month forecast

Total: 15 · Buy rate: 73.3%

The EBS analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +48.70% upside from the current price of $8.07.

Stock Performance

Full History
1D-4.38%
1W-1.59%
1M-15.05%
3M-2.65%
YTD-34.71%
1Y+24.35%
5Y-87.37%

About Emergent BioSolutions Inc.

CEOJoseph C. Papa Jr.
IPO DateNov 15, 2006
Employees900
CountryUS
Websiteemergentbiosolutions.com

Emergent BioSolutions Inc. a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats …

BiotechnologyHealthcareNYSEUS

what is emergent biosolutions inc. · ebs stock overview · emergent biosolutions inc. company profile · who is emergent biosolutions inc. ceo · ebs NYSE · emergent biosolutions inc. headquarters · emergent biosolutions inc. business segments

About Stock Overview & Key Data

Emergent BioSolutions Inc. (EBS) is a Healthcare company in the Biotechnology industry, listed on NYSE since Nov 15, 2006. As of the latest trading session, EBS stock price is $8.07, with a market capitalization of $416.4M. The stock has returned +24.35% over the past 12 months and -34.71% year-to-date.

According to 15 Wall Street analysts, the consensus rating for Emergent BioSolutions Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Emergent BioSolutions Inc. reported revenue of $742.9M and net income of $52.6M. For detailed data — including Emergent BioSolutions Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Emergent BioSolutions Inc. (EBS) stock price is $8.07. The stock is traded on NYSE under the ticker symbol EBS. The 52-week range is $5.62 – $14.06.

EBS stock priceEBS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice